Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Pascale

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2020
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective StudyMichele Bartoletti, Renato Pascale, Monica Cricca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2023
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST CohortCecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2025
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections?Linda Bussini, Davide F Bavaro, Enrico Brunetta, et al.
Open Forum Infectious Diseases|November 24, 2025
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental StudyCecilia Bonazzetti, Andrea Grechi, Dino Gibertoni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 21, 2022
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant EnterobacteralesMichele Bartoletti, Alberto Antonelli, Linda Bussini, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 26, 2021
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre studyMatteo Rinaldi, Michele Bartoletti, Alberto Ferrarese, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort studyAntonio Vena, Michela Schenone, Silvia Corcione, et al.
Plos One|May 19, 2025
Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective studySilvia Corcione, Simone Mornese Pinna, Antonio Vena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2026
Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes?Davide Fiore Bavaro, Alessandra Belati, Davide Sacchet, et al.
Infection|July 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infectionsNicholas Geremia, Federico Giovagnorio, Antonio Vena, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2020
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective StudyMichele Bartoletti, Renato Pascale, Monica Cricca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2023
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST CohortCecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2025
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections?Linda Bussini, Davide F Bavaro, Enrico Brunetta, et al.
Open Forum Infectious Diseases|November 24, 2025
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental StudyCecilia Bonazzetti, Andrea Grechi, Dino Gibertoni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 21, 2022
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant EnterobacteralesMichele Bartoletti, Alberto Antonelli, Linda Bussini, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 26, 2021
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre studyMatteo Rinaldi, Michele Bartoletti, Alberto Ferrarese, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort studyAntonio Vena, Michela Schenone, Silvia Corcione, et al.
Plos One|May 19, 2025
Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective studySilvia Corcione, Simone Mornese Pinna, Antonio Vena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2026
Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes?Davide Fiore Bavaro, Alessandra Belati, Davide Sacchet, et al.
Infection|July 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infectionsNicholas Geremia, Federico Giovagnorio, Antonio Vena, et al.
Pageof 9